ARS Pharmaceuticals, Inc.
ARS Pharmaceuticals, Inc. is a Healthcare & Life Sciences startup based in Israel, most recent round Series C+, 3 tracked investors.
About ARS Pharmaceuticals, Inc.
ARS Pharmaceuticals, Inc. is a startup founded in 2014 based in Israel. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 3 investors associated with the company.
Develops needle-free, intranasal epinephrine (neffy™ / ARS-1) for the treatment of severe allergic reactions and anaphylaxis, aiming to provide a portable, easy-to-use alternative to injectable epinephrine. The company is focused on patient-friendly delivery solutions to address needle-related risks and ease of use.
Explore ARS Pharmaceuticals, Inc.'s full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.